Entries by Christine Kelly

Update on Myozyme and Lumizyme drugs from Sanofi for Lafora Disease treatment

/by

Chelsea’s Hope continues to champion the development of effective Lafora disease (LD) therapeutics in both the research community and with interested companies. One recurring question is whether currently used therapeutics for other glycogen storage diseases could be used in LD. As you know, this would greatly benefit our community, allowing rapid therapeutic adoption. Because of […]

Shining a light on Lafora disease for Rare Disease Day 2023

/by

We will show our stripes for Lafora disease on 2023 Rare Disease Day. SACRAMENTO, Calif. – February 27, 2023 – Chelsea’s Hope Lafora Children Research Fund, a 501(c)(3) nonprofit organization, wants to share stories of Lafora disease patients like Alexis Rodriguez to raise awareness about the ultra-rare epilepsy. Lafora Disease is a degenerative neurological condition […]

New article about Lafora disease

/by

READ ARTICLE: Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders  New from Dr. Jordi Duran! It’s a review on how the accumulation of glycogen in astrocytes, glial cells in the central nervous system, contribute to Lafora disease and other neurodegenerative conditions.